Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 09, 2016 5:53 AM ET

Life Sciences Tools and Services

Company Overview of Rubicon Genomics, Inc.

Company Overview

Rubicon Genomics, Inc. engages in the development and commercialization of sample-specific nucleic acid library preparation products for use in research and clinical testing on next-generation sequencing (NGS), microarray, and q-PCR platforms. The company creates molecular biology tools for genetic, epigenetic, and expression analysis of various samples to facilitate gene-based research, drug development, and diagnostics. Its products include ThruPLEX DNA-seq kits to generate DNA libraries with expanded multiplexing capability and diversity with lower duplication rates; PicoPLEX DNA-seq kits to streamline library preparation and PicoPLEX process used by IVF clinics for pre-implantation genet...

4743 Venture Drive

Ann Arbor, MI 48108

United States

Founded in 2000

Phone:

734-677-4845

Fax:

734-477-9902

Key Executives for Rubicon Genomics, Inc.

Chairman, Chief Executive Officer and President
Age: 66
Co-Founder and Chief Scientific Officer
Chief Financial Officer
Chief Operating Officer
Vice President of Business Development
Compensation as of Fiscal Year 2015.

Rubicon Genomics, Inc. Key Developments

Rubicon Genomics, Inc. Adds Delonix Healthcare Pvt. Ltd and Biocena Ltd. as New Distributors

Rubicon Genomics, Inc. announced the addition of new distributors in India and Poland. The new distributors are Delonix Healthcare Pvt. Ltd. and Biocena Ltd.

Rubicon Genomics, Inc. Reports Sales Results for the Year 2015

Rubicon Genomics, Inc. reported sales results for the year 2015. For the year, the company reported a 40% increase in year-over-year sales in 2015.

Rubicon Genomics Announces Eurofins Scientific to Distribute its Suite of DNA Library Preparation Kits in U.S

Rubicon Genomics, Inc. announced an agreement with Eurofins Genomics for U.S. distribution of its DNA library preparation products, including the ThruPLEX DNA-seq kit and Rubicon's new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for cell-free DNA to enable the preparation of NGS libraries for liquid biopsies-the analysis of cell-free circulating DNA in plasma for diagnostic and prognostic applications in cancer and other conditions. Liquid biopsies can eliminate the need for invasive and costly tissue biopsies to detect biomarkers and other genetic mutations in tumors. They are expected to transform cancer screening, diagnostics and treatment and to replace many prenatal amniocentesis procedures. ThruPLEX Plasma-seq kits enable liquid biopsies by producing highly reproducible next-generation sequencing (NGS) libraries from small amounts of cell-free DNA in plasma, enabling accurate and informative results from samples that might otherwise be difficult or impossible to analyze. ThruPLEX Plasma-seq libraries are suitable for whole genome, whole exome and targeted gene sequencing. The performance of the ThruPLEX Plasma-seq kit has been validated by researchers at the Karolinska Institute in Sweden and Cancer Research UK (CRUK). ThruPLEX Plasma-seq can now be easily automated for high throughput applications on Beckman Coulter's Biomek FXP Liquid Handling Workstation, a leading automated solution for laboratories worldwide. ThruPLEX DNA-seq works with as little as 50 picograms of DNA and is especially efficient for challenging specimens. The entire workflow is performed in a single tube or well in about two hours and requires no purification steps or sample transfers. ThruPLEX DNA-seq produces uniform coverage and improves molecular complexity, yielding highly reproducible sequencing results.

Similar Private Companies By Industry

Company Name Region
Lavipharm Laboratories, Inc. United States
Camargo Pharmaceutical Services, LLC United States
Provident Research, Inc. United States
Bar Harbor BioTechnology, Inc. United States
Clinical Research & Development Services Corp. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
July 15, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rubicon Genomics, Inc., please visit www.rubicongenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.